scorecardresearch
'A momentous feat': PM Modi after Zydus Cadila's COVID-19 vaccine gets approval

'A momentous feat': PM Modi after Zydus Cadila's COVID-19 vaccine gets approval

Prime Minister Narendra Modi said the approval to the world's first DNA-based vaccine against the coronavirus is a testimony to the innovative zeal of India's scientists

 With the emergency use authorisation (EUA), ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country With the emergency use authorisation (EUA), ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country

With indigenously developed Zydus Cadila's COVID-19 vaccine receiving emergency use authorisation, Prime Minister Narendra Modi on Friday hailed it as a "momentous feat" and said the approval of the world's first DNA-based vaccine against the coronavirus is a testimony to the innovative zeal of India's scientists. 

The Department of Biotechnology on Friday said the indigenously developed Zydus Cadila COVID-19 vaccine ZyCoV-D has received approval for emergency use authorisation from the Drug Controller General of India and it will be administered to people 12 years and above. 

Also Read: COVID-19 vaccine: SEC recommends emergency approval for Zydus Cadila's ZyCoV-D

With the emergency use authorisation (EUA), ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country. 

"India is fighting COVID-19 with full vigour. The approval for the world's first DNA based 'ZyCov-D' vaccine of @ZydusUniverse is a testimony to the innovative zeal of India's scientists," Prime Minister Modi tweeted. 

"A momentous feat indeed," he added. 

Vaccines Covishield, Covaxin and Sputnik V are being given to only those above 18 years of age and unlike ZyCoV-D, which is three-dose, these are administered in two doses. 

The Department of Biotechnology (DBT) said that ZyCoV-D is the world's first DNA-based vaccine against the coronavirus and when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance. 

Also Read: Zydus Cadila Q1 net profit rises 29% to Rs 587 cr, revenue up 15%